DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

company name or ticker
Company Photos
(Click to zoom)

Alnylam And Benitec

Cramer's Mad Money - 2 Picks From Leon Cooperman (7/24/14)

Merck Looks Overpriced Compared To This Sector Peer

Keep Calm and Carry On, Roche Stock

Roche continues to build upon the strongest oncology franchise in Big Pharma but could still use some non-oncology hits

Daily Dividend Report: INTC, MRK, V, BLK, AAL

Daily Dividend Report: INTC, MRK, V, BLK, AAL

Gilead Sciences Q2 2014: All Is Good, More To Come At Medical Conferences Later This Year

Merck & Co. Inc.: I'm Long, But It Screams Overvalued Today

Is Inovio Undervalued After Positive HPV Therapy Results?

Roche Earnings Preview: Continued Adoption For Key Cancer Drugs Will Drive Growth

3 Things You Need to Watch on Gilead Sciences Inc. Earnings Call

Competition with AbbVie and Merck is important, but hepatitis C shouldn't be your sole focus.